Smart Phone ACT Treatment for Adults With Longstanding Pain - a Pilot Study
NCT ID: NCT03344926
Last Updated: 2020-01-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
34 participants
INTERVENTIONAL
2017-10-23
2019-12-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The hypotheses are that
1. ACTsmart will be a feasible and accessable treatment delivery form
2. ACTsmart will improve function and quality of life
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
ACTION: Trial of Adding Buprenorphine, CBT, and TMS to Improve Outcomes of Long-Term Opioid Therapy for Chronic Pain
NCT06442566
Tapering From Long-term Opioid Therapy in Chronic Pain Population. Randomized Controlled Trial With 12 Months Follow up
NCT03485430
Long-Term Opioid Therapy in Chronic Non-Cancer Pain: Risks and Benefits
NCT06063902
Treatment of Withdrawal Symptoms With NADA Acupuncture in Chronic Pain Patients
NCT03397212
Delivering Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention in Opioid Use Disorder
NCT05053503
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Internet-delivered ACT Despite the increased empirical support for ACT the availability is still very limited, and a large number of patients do not receive this treatment. In other domains, the accessibility of empirically supported treatments has increased during the past decade due to the development of methods to deliver the treatment via internet. For example, a large number of studies illustrate the utility of internet-delivered CBT for anxiety, insomnia and depression, with treatment effects similar to those obtained in studies with face-to-face treatment. Few studies have yet evaluated internet-delivered ACT (iACT) for chronic pain, but a recent pilot study from our group with participants suffering from fibromyalgia (n=41) illustrated very promising results that warrant further studies to evaluate the effects of this treatment.
To make treatment more accessible and present in patients' daily life we will use a smart phone application to deliver treatment.
Recruitment Patients will be recruited through self referral. Information regarding the study will be provided through newspapers and social media, as well as in direct communication with pain clinics and primary care units, including instructions regarding e.g. eligibility and how to sign up. Once patients have been found eligible and expressed interest in study participation they will be assessed by a psychologist, and when needed by a pain physician, via semi-structured interviews to confirm eligibility and to ensure that the patient meet the study criteria. Informed consent is obtained from all participants prior to the assessment.
Statistical methods Evaluations of treatment effects are primarily based on intent-to-treat analyses. The statistical approach will primarily be based on linear multilevel modeling (LMM), which takes into account dependencies between repeated measures and differences between patients in pre-treatment status and treatment response (i.e. random effects modeling) and also provide means of handling missing data. More traditional methods, such as ANOVA and hierarchical regression, may also be utilized when appropriate.
Interviews Evaluations of feasibility and as a base for further development of the smart phone application will be done via semi structured interviews during and after treatment period.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ACTsmart
ACT treatment via a smart phone application
ACTsmart
Participant receive ACT treatment via a smart phone application, including psychologist support via a message function within the application.
Treatment content is divided into four modules:
1. education about pain behaviors, exposure and acceptance and commitment therapy
2. education about pain physiology
3. exercises on changing behaviors, acceptance, mindfulness, defusion and exposure
4. value based exposure in the participant's daily life
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ACTsmart
Participant receive ACT treatment via a smart phone application, including psychologist support via a message function within the application.
Treatment content is divided into four modules:
1. education about pain behaviors, exposure and acceptance and commitment therapy
2. education about pain physiology
3. exercises on changing behaviors, acceptance, mindfulness, defusion and exposure
4. value based exposure in the participant's daily life
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* able to read and write in Swedish
* have access to a smart phone with internet access
* no planned changes in medication use, or any other changes in interventions for their pain planned
Exclusion Criteria
* unstable medication (planned changes in medication during next 4 months)
* ACT or CBT treatment during the past 3 months
* severe psychiatric co-morbidity (e.g. high risk of suicide) as assessed by the psychologist in a semi-structured interview
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AFA Insurance
INDUSTRY
Rikard Wicksell
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rikard Wicksell
Associate professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rikard Wicksell
Role: PRINCIPAL_INVESTIGATOR
Karolinska Institutet
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Karolinska institutet
Stockholm, Stockholm County, Sweden
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Gentili C, Zetterqvist V, Rickardsson J, Holmstrom L, Ljotsson B, Wicksell R. Examining predictors of treatment effect in digital Acceptance and Commitment Therapy for chronic pain. Cogn Behav Ther. 2023 Jul;52(4):380-396. doi: 10.1080/16506073.2023.2191826. Epub 2023 Mar 27.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2015/1638-31/2:2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.